FitLife Brands, Inc. (FTLF) stock
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/302% below fair value
$6.83+0.00 (0.00%)
Close on Nov 17, 2026Market cap $64.14MP/E 35.9Yield –
FitLife Brands revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
FitLife Brands's revenue for the twelve months ending Jun 30, 2026 was $101.27M. For fiscal 2025 it was $15.94M, down 75.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $64.47M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.94M | -75.3% |
| FY2024 | Dec 31, 2024 | $64.47M | +22.3% |
| FY2023 | Dec 31, 2023 | $52.70M | +83.0% |
| FY2022 | Dec 31, 2022 | $28.80M | +3.2% |
| FY2021 | Dec 31, 2021 | $27.91M | +26.2% |
| FY2020 | Dec 31, 2020 | $22.11M | +15.5% |
| FY2019 | Dec 31, 2019 | $19.14M | +12.1% |
| FY2018 | Dec 31, 2018 | $17.08M | -4.1% |
| FY2017 | Dec 31, 2017 | $17.80M | -29.7% |
| FY2016 | Dec 31, 2016 | $25.31M | +41.2% |
| FY2015 | Dec 31, 2015 | $17.93M | -10.2% |
| FY2014 | Dec 31, 2014 | $19.96M | +1.4% |
| FY2013 | Dec 31, 2013 | $19.68M | +8.8% |
| FY2012 | Dec 31, 2012 | $18.09M | +49.6% |
| FY2011 | Dec 31, 2011 | $12.09M | +48.4% |
| FY2010 | Dec 31, 2010 | $8.15M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.55M | +76.8% |
| Q1 FY2026 | Mar 31, 2026 | $25.33M | +58.5% |
| Q4 FY2025 | Dec 31, 2025 | $25.91M | +53.0% |
| Q3 FY2025 | Sep 30, 2025 | $23.49M | +41.9% |
| Q4 FY2024 | Dec 31, 2024 | $15.01M | +12.9% |
| Q3 FY2024 | Sep 30, 2024 | $15.98M | +14.9% |
| Q2 FY2024 | Jun 30, 2024 | $16.93M | +14.7% |
| Q1 FY2024 | Mar 31, 2024 | $16.55M | +54.1% |
| Q4 FY2023 | Dec 31, 2023 | $13.30M | +147.7% |
| Q3 FY2023 | Sep 30, 2023 | $13.90M | +67.2% |
| Q2 FY2023 | Jun 30, 2023 | $14.76M | +88.7% |
| Q1 FY2023 | Mar 31, 2023 | $10.74M | +47.2% |
| Q4 FY2022 | Dec 31, 2022 | $5.37M | -25.4% |
| Q3 FY2022 | Sep 30, 2022 | $8.31M | +24.0% |
| Q2 FY2022 | Jun 30, 2022 | $7.82M | -6.9% |
| Q1 FY2022 | Mar 31, 2022 | $7.29M | +30.3% |
| Q4 FY2021 | Dec 31, 2021 | $7.20M | +15.5% |
| Q3 FY2021 | Sep 30, 2021 | $6.71M | +5.7% |
| Q2 FY2021 | Jun 30, 2021 | $8.41M | +181.1% |
| Q1 FY2021 | Mar 31, 2021 | $5.60M | -14.4% |
| Q4 FY2020 | Dec 31, 2020 | $6.23M | +72.3% |
| Q3 FY2020 | Sep 30, 2020 | $6.35M | +10.8% |
| Q2 FY2020 | Jun 30, 2020 | $2.99M | -30.5% |
| Q1 FY2020 | Mar 31, 2020 | $6.54M | +19.2% |
| Q4 FY2019 | Dec 31, 2019 | $3.62M | +3.4% |
| Q3 FY2019 | Sep 30, 2019 | $5.73M | +24.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.30M | -1.8% |
| Q1 FY2019 | Mar 31, 2019 | $5.49M | +19.0% |
| Q4 FY2018 | Dec 31, 2018 | $3.50M | +10.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.58M | +13.8% |
| Q2 FY2018 | Jun 30, 2018 | $4.38M | -12.8% |
| Q1 FY2018 | Mar 31, 2018 | $4.61M | -17.5% |
| Q4 FY2017 | Dec 31, 2017 | $3.16M | -14.5% |
| Q3 FY2017 | Sep 30, 2017 | $4.03M | -24.6% |
| Q2 FY2017 | Jun 30, 2017 | $5.02M | -42.0% |
| Q1 FY2017 | Mar 31, 2017 | $5.59M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.70M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.34M | – |
| Q2 FY2016 | Jun 30, 2016 | $8.66M | – |
See a number that looks wrong?